Skip to main content
Go to the home page of the European Commission (opens in new window)
English en
CORDIS - EU research results
CORDIS

Proteome-wide Functional Interrogation and Modulation of Gut Microbiome Species

Project description

Systems biology study of functions and interactions of human gut microbiome proteins

Genomics approaches identify imbalances and associations of human gut microbiota species composition with the disease. However, the molecular mechanisms that drive disease or promote health and functions of many proteins of these organisms are not understood. The ERC-funded ProFITGut project will attempt to identify functions and interactions of microbiome species proteins and develop strategies to manipulate microbiome composition. The study will employ a scalable systems biology approach involving high-throughput proteomics, and drugs, targeting the proteome of 38 prevalent and diverse bacterial species in the human gut. The goals are to create a map of the functional protein network of these species, identify the mechanisms of action and species that encode the target, providing information for specific depletion of the disease-associated species.

Objective

The gut microbiome plays a key role in human health. Genomics approaches excel at cataloguing species composition, and associating imbalances with disease. Yet, as we are oblivious to the function of a large proportion of proteins of these organisms, we are limited in our understanding of the molecular mechanisms that drive disease or promote health. In this groundbreaking project we will systematically identify the function and interactions of proteins of microbiome species, deliver compounds to modulate them, and develop strategies to rationally manipulate microbiome composition.
We will use a scalable systems biology approach based on high-throughput proteomics, using more than 100 drugs to perturb the proteome of a panel of 38 prevalent and phylogenetically diverse bacterial species that colonize the human gut. Proteins involved in the same biological process have coordinated changes in their levels across perturbations, allowing us to infer function based on annotated proteins. We will further assess which proteins are likely to physically interact as they co-aggregate upon heat-induced denaturation, leading to a map of the functional protein network of these species. We will then identify the mechanisms of action and resistance of the used drugs by using thermal proteome profiling, and by measuring intracellular drug concentrations. This will allow us to identify species that encode the target, but no resistance elements, so we can use the information to specifically deplete disease-associated species from microbial communities. These strategies extend beyond the strains studied in this project, as homologs of these proteins can be identified solely from genome sequences.
Overall, this project paves the way for the microbiome field to move from associations to targetable mechanisms, with a vision to design therapies with reduced side effects to restore the microbiome to a healthy state.

Fields of science (EuroSciVoc)

Keywords

Programme(s)

Topic(s)

Funding Scheme

HORIZON-ERC - HORIZON ERC Grants

See all projects funded under this funding scheme

Call for proposal

(opens in new window) ERC-2022-STG

See all projects funded under this call

Host institution

UMEA UNIVERSITET
Net EU contribution
€ 1 499 980,00
Address
UNIVERSITETOMRADET
901 87 UMEA
Sweden
Region
Östra Sverige Stockholm Stockholms län
Activity type
Higher or Secondary Education Establishments
Links
Total cost
€ 1 499 980,00

Beneficiaries (1)